BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16906583)

  • 21. CD38+ chronic lymphocytic leukaemia cells co-express high levels of ZAP-70 and are functionally distinct from their CD38- counter-parts.
    Pepper C; Brennan P; Alghazal S; Ward R; Pratt G; Starczynski J; Lin T; Rowntree C; Fegan C
    Leukemia; 2006 Apr; 20(4):743-4. PubMed ID: 16452999
    [No Abstract]   [Full Text] [Related]  

  • 22. ZAP-70 expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV(H) mutations.
    Zucchetto A; Bomben R; Bo MD; Nanni P; Bulian P; Rossi FM; Del Principe MI; Santini S; Del Poeta G; Degan M; Gattei V
    Cytometry B Clin Cytom; 2006 Jul; 70(4):284-92. PubMed ID: 16906587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic markers in chronic lymphocytic leukaemia.
    Hamblin TJ
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):455-68. PubMed ID: 17707833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New prognostic markers in chronic lymphocytic leukemia.
    Moreno C; Montserrat E
    Blood Rev; 2008 Jul; 22(4):211-9. PubMed ID: 18448218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of bone marrow and peripheral blood ZAP-70 status examined by flow cytometric immunophenotyping in patients with chronic lymphocytic leukemia.
    Sheridan R; Mounajjed T; Ehrmann DE; Hurtubise PE; Schrager JA
    Cytometry B Clin Cytom; 2006 Jul; 70(4):320-1. PubMed ID: 16906578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Soma LA; Craig FE; Swerdlow SH
    Hum Pathol; 2006 Feb; 37(2):152-9. PubMed ID: 16426914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discordant results of flow cytometric ZAP-70 expression status in B-CLL samples if different gating strategies are applied.
    Wilhelm C; Neubauer A; Brendel C
    Cytometry B Clin Cytom; 2006 Jul; 70(4):242-50. PubMed ID: 16906574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
    Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [ZAP-70 expression in 24 patients with B cell chronic lymphocytic leukemia].
    Wu YJ; Li JY; Zhu GR; Song JH; Xiao B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):237-40. PubMed ID: 16638188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prognostic markers of CLL--"watch and wait" and transplantation].
    Cetkovský P
    Vnitr Lek; 2006 Dec; 52(12):1148-9. PubMed ID: 17299906
    [No Abstract]   [Full Text] [Related]  

  • 31. Peripheral blood and bone marrow TNF and TNF receptors in early and advanced stages of B-CLL in correlation with ZAP-70 protein and CD38 antigen.
    Bojarska-Junak A; Hus I; Szczepanek EW; Dmoszyńska A; Roliński J
    Leuk Res; 2008 Feb; 32(2):225-33. PubMed ID: 17675228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia.
    Morabito F; Cutrona G; Gentile M; Matis S; Todoerti K; Colombo M; Sonaglio C; Fabris S; Reverberi D; Megna M; Spriano M; Lucia E; Rossi E; Callea V; Mazzone C; Festini G; Zupo S; Molica S; Neri A; Ferrarini M
    Br J Haematol; 2009 Jun; 146(1):44-53. PubMed ID: 19438486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction: Chronic lymphocytic leukemia in perspective.
    Rai KR
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):363-5. PubMed ID: 17707826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
    Abousamra NK; El-Din MS; Azmy E
    Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of ZAP-70 and CD 38 in Indian chronic lymphocytic leukemia patients.
    Gogia A; Sharma A; Raina V; Kumar L; Gupta R; Kumar R
    Indian J Cancer; 2013; 50(4):333-6. PubMed ID: 24369212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of flow cytometric measurement of ZAP-70 in chronic lymphocytic leukemia.
    Preobrazhensky SN; Bahler DW
    Cytometry B Clin Cytom; 2008 Mar; 74(2):118-27. PubMed ID: 17948236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ZAP-70 intron1 DNA methylation status: determination by pyrosequencing in B chronic lymphocytic leukemia.
    Chantepie SP; Vaur D; Grunau C; Salaün V; Briand M; Parienti JJ; Heutte N; Cheze S; Roussel M; Gauduchon P; Leporrier M; Krieger S
    Leuk Res; 2010 Jun; 34(6):800-8. PubMed ID: 19944462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. D cyclins in CD5+ B-cell lymphoproliferative disorders: cyclin D1 and cyclin D2 identify diagnostic groups and cyclin D1 correlates with ZAP-70 expression in chronic lymphocytic leukemia.
    Meyerson HJ; MacLennan G; Husel W; Cocco A; Tse W; Lazarus HM; Kaplan D
    Am J Clin Pathol; 2006 Feb; 125(2):241-50. PubMed ID: 16393687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD38 as a prognostic factor in B cell chronic lymphocytic leukaemia (B-CLL): comparison of three approaches to analyze its expression.
    Boonstra JG; van Lom K; Langerak AW; Graveland WJ; Valk PJ; Kraan J; van 't Veer MB; Gratama JW
    Cytometry B Clin Cytom; 2006 May; 70(3):136-41. PubMed ID: 16568475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of CD38 and ZAP70 mRNA expression among cytogenetic subgroups of Iranian chronic-lymphocytic-leukemia patients.
    Teimori H; Akbari MT; Hamid M; Forouzandeh M; Bibordi E
    Genet Mol Res; 2011 Oct; 10(4):2415-23. PubMed ID: 22002134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.